Contents

Current Pharmaceutical Design, Volume 16 - Number 36

Editorial [Hot topic: Current Status of Drug Eluting Stents (Executive Editor: Nicholas Kipshidze)]

, 16(36): 3977

Nicholas Kipshidze


DOI: 10.2174/138161210794454932




Polymers for Drug Eluting Stents

, 16(36): 3978 - 3988

Ted Parker, Vipul Dave and Robert Falotico


DOI: 10.2174/138161210794454897




Anti-Proliferative Compounds for the Prevention of Restenosis: Anti-Restenotic Mechanisms of Paclitaxel Action

, 16(36): 3989 - 4001

Mark C. Lavigne, Michael J. Eppihimer, Ruth Cheng and James J. Barry


DOI: 10.2174/138161210794454888




Sirolimus and its Analogs and its Effects on Vascular Diseases

, 16(36): 4002 - 4011

Steven J. Adelman


DOI: 10.2174/138161210794454923




Clinical Studies with Sirolimus, Zotarolimus, Everolimus and Biolimus A9 Drug- Eluting Stent Systems

, 16(36): 4012 - 4024

Bimmer E. Claessen, Jose P.S. Henriques and George D. Dangas


DOI: 10.2174/138161210794454941




Clinical Studies with Paclitaxel - Eluting Stent Systems

, 16(36): 4025 - 4036

Neeraj R. Bajaj and Kirk N. Garratt


DOI: 10.2174/138161210794454860




Drug Eluting Stents for Vulnerable Plague

, 16(36): 4037 - 4040

Konstantinos Toutouzas, Andreas Synetos and Christodoulos Stefanadis


DOI: 10.2174/138161210794454914




Biodegradable and Bioabsorbable Stents

, 16(36): 4041 - 4051

Ron Waksman and Rajbabu Pakala


DOI: 10.2174/138161210794454905




Stent Thrombosis and Duration of Dual Antiplatelet Therapy

, 16(36): 4052 - 4063

Alfonso Ielasi, Rasha Al-Lamee and Antonio Colombo


DOI: 10.2174/138161210794454851




Pathobiology of Stent Thrombosis after Drug-Eluting Stent Implantation

, 16(36): 4064 - 4071

Marc Vorpahl, Saami K. Yazdani, Masataka Nakano, Elena Ladich, Frank D. Kolodgie, Aloke V. Finn and Renu Virmani


DOI: 10.2174/138161210794454879




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science